Chlamydia pneumoniae in Cardiovascular Disease: Update on Chsp60 and other Emerging Virulence Determinants

ISSN： 1567-2034

Source： Medicinal Chemistry Reviews - Online, Vol.1, Iss.4, 2004-10, pp. : 475-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chlamydia pneumoniae: risk factor for cardiovascular disease?

Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Proteomics and Cardiovascular Disease: An Update

Current Medicinal Chemistry, Vol. 15, Iss. 6, 2008-03 ,pp. : 555-572

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Chlamydia pneumoniae infection and chronic obstructive pulmonary disease

By Beder Sumru Karnak Demet

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. : 1461-1470

Informa Healthcare

Access to resources Recommend Favorite

Heat Shock Protein-60 and Risk for Cardiovascular Disease

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3662-3668

Bentham Science Publishers

Access to resources Recommend Favorite

Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5267-5280

Bentham Science Publishers

Access to resources Recommend Favorite